Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Y Yu

Showing results (41-50 of 234) with videos related to

Pageof 24
Sort By:
Clinical Genitourinary Cancer|December 31, 2017
DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223Jorge D Ramos, Elahe A Mostaghel, Colin C Pritchard, et al.
Anticancer Research|April 27, 2024
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel TherapyTaylor Amery, Shaadi Tabatabaei, Maya Sonpatki, et al.
The Oncologist|March 8, 2021
Disparities in Cancer Care and the Asian American PopulationRichard J Lee, Ravi A Madan, Jayoung Kim, et al.
Clinical Genitourinary Cancer|April 18, 2015
Persistent, Unexplained Leukocytosis Is a Paraneoplastic Syndrome Associated With a Poor Prognosis in Patients With Urothelial CarcinomaJason P Izard, John L Gore, Elahe A Mostaghel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2024
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to CareRavi A Madan, Evan Y Yu, Edwin M Posadas, et al.
Clinical Nuclear Medicine|May 21, 2025
The Role of SPECT/CT in 177Lu-PSMA-617 Theranostics: Case-based Review of Response and Progression PatternsAlireza Ghodsi, Ridvan Arda Demirci, Delphine L Chen, et al.
Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
Cancer|March 7, 2019
Delays in radical cystectomy for muscle-invasive bladder cancerAlice T Chu, Sarah K Holt, Jonathan L Wright, et al.
Clinical Genitourinary Cancer|September 23, 2014
Relationships between times to testosterone and prostate-specific antigen rises during the first off-treatment interval of intermittent androgen deprivation are prognostic for castration resistance in men with nonmetastatic prostate cancerKevin F Kuo, Rachel Hunter-Merrill, Roman Gulati, et al.
Clinical Genitourinary Cancer|March 18, 2020
Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the LiteratureLeonidas N Diamantopoulos, Ali R Khaki, Guru P Sonpavde, et al.
Pageof 24

Showing results (41-50 of 234) with videos related to

Sort By:
Pageof 24
Clinical Genitourinary Cancer|December 31, 2017
DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223Jorge D Ramos, Elahe A Mostaghel, Colin C Pritchard, et al.
Anticancer Research|April 27, 2024
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel TherapyTaylor Amery, Shaadi Tabatabaei, Maya Sonpatki, et al.
The Oncologist|March 8, 2021
Disparities in Cancer Care and the Asian American PopulationRichard J Lee, Ravi A Madan, Jayoung Kim, et al.
Clinical Genitourinary Cancer|April 18, 2015
Persistent, Unexplained Leukocytosis Is a Paraneoplastic Syndrome Associated With a Poor Prognosis in Patients With Urothelial CarcinomaJason P Izard, John L Gore, Elahe A Mostaghel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2024
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to CareRavi A Madan, Evan Y Yu, Edwin M Posadas, et al.
Clinical Nuclear Medicine|May 21, 2025
The Role of SPECT/CT in 177Lu-PSMA-617 Theranostics: Case-based Review of Response and Progression PatternsAlireza Ghodsi, Ridvan Arda Demirci, Delphine L Chen, et al.
Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
Cancer|March 7, 2019
Delays in radical cystectomy for muscle-invasive bladder cancerAlice T Chu, Sarah K Holt, Jonathan L Wright, et al.
Clinical Genitourinary Cancer|September 23, 2014
Relationships between times to testosterone and prostate-specific antigen rises during the first off-treatment interval of intermittent androgen deprivation are prognostic for castration resistance in men with nonmetastatic prostate cancerKevin F Kuo, Rachel Hunter-Merrill, Roman Gulati, et al.
Clinical Genitourinary Cancer|March 18, 2020
Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the LiteratureLeonidas N Diamantopoulos, Ali R Khaki, Guru P Sonpavde, et al.
Pageof 24